Abstract: The invention relates to the use of lithium-2-pentafluoroethoxy-1,1,2,2-tetrafluoro-ethanesulfonate as a conductive salt in lithium-based energy stores and to electrolytes containing lithium-2-pentafluoroethoxy-1,1,2,2-tetrafluoro-ethanesulfonate.

Abstract: The invention relates to a method for producing carbon-coated, transition metal-doped zinc oxide particles and the use thereof as electrode material for alkali metal ion batteries and, in particular, lithium ion batteries.

Abstract: The present invention relates to an isolated polypeptide comprising at least one intein or at least one intein fragment of said intein, wherein said intein is a naturally split intein with a N-terminal intein fragment split after 14-60 amino acids from the intein's N-terminal end and methods of using the same.

Abstract: The invention relates to lithium-2-methoxy-1,1,2,2-tetrafluoro-ethanesulfonate, to the use thereof as conductive salt in lithium-based energy accumulators, and ionic liquids comprising 2-methoxy-1,1,2,2-tetrafluoro-ethanesulfonate as an anion.

Abstract: The invention relates to an electrolyte for a lithium-based energy storage device comprising at least one lithium salt, a solvent and at least one compound of general formula (1), and to their use in lithium-based energy storage devices.

Abstract: The present invention relates to a method and a device for providing a current of spin-polarized electrons. More particularly, the present invention is suited for use in spin electronics or detection of spin-polarized electrons.

Abstract: The present invention relates to a process for the enzymatic production of a dipeptide composition from a cyanophycin (CGP) or CGP-like polymer preparation by degrading the polymer preparation with an CGPase, a CGPase particularly adapted for said process, and the use of cyanophycin (CGP) or CGP-like polymers or fragments thereof, notably a dipeptide composition obtained by the process as defined above, as pharmaceutical composition, medicament, or as food or feed substitute.

Abstract: The present invention relates to a process for the enzymatic production of a dipeptide composition from a cyanophycin (CGP) or CGP-like polymer preparation by degrading the polymer preparation with an CGPase, a CGPase particularly adapted for said process, and the use of cyanophycin (CGP) or CGP-like polymers or fragments thereof, notably a dipeptide composition obtained by the process as defined above, as pharmaceutical composition, medicament, or as food or feed substitute.

Abstract: The invention relates to lithium-2-methoxy-1,1,2,2-tetrafluoro-ethanesulfonate, to the use thereof as conductive salt in lithium-based energy accumulators, and ionic liquids comprising 2-methoxy-1,1,2,2-tetrafluoro-ethanesulfonate as an anion.

Abstract: A method of synthesizing Pyrazoles by means of the oxidative conversion of Enamines with suitable N-containing carboxylic acid derivatives in the presence of copper ions and 2-picolinic acid derivatives is provided.

Abstract: A method includes introducing the examination object into an examination region of a combination device; recording emission computed tomography data over a measurement period and storing detection events and detection instants associated therewith; measuring magnetic resonance data of at least two subregions of the examination region at at least two instants during the recording period of the emission computed tomography data and storing the magnetic resonance data and the recording instants; determining motion information describing a motion of a region of the examination object at a first instant relative to the position at a second instant from the magnetic resonance data recorded at the first instant and the second instant, for each subregion; determining a motion model describing motion of the examination object, for the entire object, from information for the subregions; and calculating motion-corrected emission tomography data from detection events, detection instants and the motion model.

Abstract: The present invention is directed to a method for determining nuclear DNA (nDNA) in sperm sample by means of Raman micro-spectroscopy. In particular, the method is useful to determine the presence of intact and/or damaged nDNA in a sperm. Further, the present invention is directed to a method for screening sperm for in vitro fertilization or artificial reproduction treatment (ART).

Abstract: The present subject matter can include a two-dimensional electrochemical writing assembly and uses thereof. The writing assembly can enable for time-dependently displaying of a physical parameter, such as a time-dependent display or recording of the temperature. The writing assembly comprises two different types of electrochemical processors, of which one type is used for controlling the time-dependent switching of the second type of electrochemical processors used in the writing assembly.

Abstract: The invention relates to an electrolyte, comprising at least one lithium salt, a solvent, and at least one compound according to general formula (1). The invention further relates to lithium-based energy stores comprising such an electrolyte.

Abstract: The invention describes a novel process for synthesizing pyrazoles by means of oxidative conversion of enamines with suitable N-containing carboxylic acid derivatives.

Abstract: An in vitro method of screening candidate compounds for the preventive or curative treatment of rosacea is described. The method can include determining the capacity of a compound to modulate the expression or activity of the Transient Receptor Potential (TRPs), as well as the use of modulators of the expression or activity of this transcription factor for the treatment of rosacea. The method can also include in vitro diagnosis or prognosis of this pathology.

Abstract: The present invention relates to nitric oxide releasing compounds and their use in the prevention, amelioration and/or therapy of nitric oxide (NO) deficiency induced disturbances of the cerebral microcirculation. The NO deficiency induced disturbances of the cerebral microcirculation may be due to an intracranial hemorrhage or stroke and can cause cerebrovascular spasms (or cerebral vasospasms) (CVS) and/or malperfusion of brain parenchyma caused by blood vessel and blood flow dysregulation which, in turn, can cause secondary neurological deficiencies (DIND) and/or brain infarction. Particularly, the present invention relates to the prevention, amelioration and/or therapy of delayed cerebral vasospasm-associated disorders after survived subarachnoidal hemorrhage by applying a NO-donor, most preferably Molsidomine.

Abstract: An apparatus and a method for activation of at least one element. The apparatus comprises at least one activation layer and at least one migration layer arranged at the at least one activation layer and being permeable to a fluid along a transversal direction across a surface of the at least one migration layer, such that a change of doping level in the at least one activation layer is achieved, for activating the at least one activation layer along the transversal direction, wherein a substrate onto which the activation layer and the migration layer are deposited comprises an opening being sealed by a gas permeable membrane, the gas-permeable membrane being in contact with a fluid container.

Abstract: The present subject matter can include a two-dimensional electrochemical writing assembly and uses thereof. The writing assembly can enable for time-dependently displaying of a physical parameter, such as a time-dependent display or recording of the temperature. The writing assembly comprises two different types of electrochemical processors, of which one type is used for controlling the time-dependent switching of the second type of electrochemical processors used in the writing assembly.

Abstract: Markers for rosacea among the chemokines and cytokines and their receptors, selected from interleukin 8 (IL-8), CXCL1, CXCL2, CXCL3 and CXCL5, the CXCR1 receptor and the CXCR2 receptor are described. Also described, is a method for the diagnosis of rosacea.